These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22027578)

  • 1. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.
    Byrnes V; Miller A; Lowry D; Hill E; Weinstein C; Alsop D; Lenkinski R; Afdhal NH
    J Hepatol; 2012 Mar; 56(3):549-56. PubMed ID: 22027578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes.
    Pattullo V; McAndrews MP; Damyanovich A; Heathcote EJ
    Liver Int; 2011 Aug; 31(7):1028-38. PubMed ID: 21733093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
    Bokemeyer M; Ding XQ; Goldbecker A; Raab P; Heeren M; Arvanitis D; Tillmann HL; Lanfermann H; Weissenborn K
    Gut; 2011 Mar; 60(3):370-7. PubMed ID: 20926642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.
    Forton DM; Thomas HC; Murphy CA; Allsop JM; Foster GR; Main J; Wesnes KA; Taylor-Robinson SD
    Hepatology; 2002 Feb; 35(2):433-9. PubMed ID: 11826420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Rami L; Gómez-Ansón B; Bosch B; Sánchez-Valle R; Monte GC; Villar A; Molinuevo JL
    Dement Geriatr Cogn Disord; 2007; 24(4):274-9. PubMed ID: 17717413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased frontal choline and neuropsychological performance in preclinical Huntington disease.
    Gómez-Ansón B; Alegret M; Muñoz E; Sainz A; Monte GC; Tolosa E
    Neurology; 2007 Mar; 68(12):906-10. PubMed ID: 17372125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
    Kim EA; Cheong HK; Choi DS; Sakong J; Ryoo JW; Park I; Kang DM
    Neurotoxicology; 2007 Mar; 28(2):276-83. PubMed ID: 16824604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania.
    Malhi GS; Ivanovski B; Wen W; Lagopoulos J; Moss K; Sachdev P
    Acta Psychiatr Scand Suppl; 2007; (434):57-66. PubMed ID: 17688464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes.
    Valenzuela MJ; Sachdev PS; Wen W; Shnier R; Brodaty H; Gillies D
    Neuroimage; 2000 Dec; 12(6):747-56. PubMed ID: 11112406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.